Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs United Airlines Holdings Inc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.08B), while United Airlines Holdings Inc trades at $99.4 (market cap $32.12B). The key difference: United Airlines Holdings Inc is far larger — about 6.3× Oruka Therapeutics Inc. Common Stock's market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and United Airlines Holdings Inc for 46 Days on average.
| ORKA | UAL | |
|---|---|---|
Market Cap | $5.08B | $32.12B |
Volume | 685,276 | 5,419,148 |
Sector | Health | Industrials |
52-Week High | $113.08 | $136.11 |
52-Week Low | $26.19 | $85.21 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $4.21B | $49.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
United Airlines (UAL) trades at $103.21, down 1.18% on the day, with a bearish technical signal from moving averages but oversold RSI suggesting potential near-term support. Fundamentally, the stock appears undervalued with a P/E of 9.67 and P/S of 0.54, supported by consistent earnings beats and a 5.56% net margin. Recent news highlights aggressive customer acquisition efforts targeting Delta's premium flyers with status-match offers and Starlink WiFi enhancements.
The outlook is mixed: strong analyst consensus (66% buy ratings) and a $158.10 price target imply 53% upside, but rising fuel costs and bearish technicals pose near-term headwinds. Earnings growth and market share gains from strategic moves present opportunity, while operational execution and cost management remain key risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
